rs9328349

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000129.4(F13A1):​c.319+17956A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0746 in 152,242 control chromosomes in the GnomAD database, including 1,109 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.075 ( 1109 hom., cov: 33)

Consequence

F13A1
NM_000129.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.619

Publications

0 publications found
Variant links:
Genes affected
F13A1 (HGNC:3531): (coagulation factor XIII A chain) This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13A1 Gene-Disease associations (from GenCC):
  • factor XIII, A subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.219 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F13A1NM_000129.4 linkc.319+17956A>C intron_variant Intron 3 of 14 ENST00000264870.8 NP_000120.2
LOC124901253XR_007059428.1 linkn.54+1455T>G intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F13A1ENST00000264870.8 linkc.319+17956A>C intron_variant Intron 3 of 14 1 NM_000129.4 ENSP00000264870.3

Frequencies

GnomAD3 genomes
AF:
0.0745
AC:
11328
AN:
152124
Hom.:
1106
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.223
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0324
Gnomad ASJ
AF:
0.0219
Gnomad EAS
AF:
0.0687
Gnomad SAS
AF:
0.0864
Gnomad FIN
AF:
0.00679
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.00844
Gnomad OTH
AF:
0.0506
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0746
AC:
11360
AN:
152242
Hom.:
1109
Cov.:
33
AF XY:
0.0744
AC XY:
5539
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.223
AC:
9243
AN:
41518
American (AMR)
AF:
0.0323
AC:
495
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0219
AC:
76
AN:
3470
East Asian (EAS)
AF:
0.0687
AC:
355
AN:
5170
South Asian (SAS)
AF:
0.0859
AC:
414
AN:
4820
European-Finnish (FIN)
AF:
0.00679
AC:
72
AN:
10610
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.00844
AC:
574
AN:
68028
Other (OTH)
AF:
0.0548
AC:
116
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
465
930
1394
1859
2324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0396
Hom.:
106
Bravo
AF:
0.0822
Asia WGS
AF:
0.0880
AC:
304
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.4
DANN
Benign
0.52
PhyloP100
0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9328349; hg19: chr6-6287628; API